Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Studied for treating type 2 diabetes due to its glucose-lowering effects in test models
Conclusion Although lower insulin levels, lower IR and protected glucose metabolism are widely reported in PWS patients, the causes are still mysterious
Patient Perspective For people with type 2 diabetes, CagriSema offered stronger weight and glucose benefits than typically seen with semaglutide alone
However, there have been no definitive clinical trials
US$ 20.46
US$ 27.63
US$ 22.88
